Anti-JCV Antibody Prevalence in a French Cohort of MS Patients under Natalizumab

被引：0
|
作者：
Outteryck, Olivier [1 ]
Ongagna, Jean-Claude [2 ]
Zephir, Helene [1 ]
Collongues, Nicolas [2 ]
Lacour, Arnaud [1 ]
Fleury, Marie [2 ]
Berteloot, Anne-Sophie [1 ]
Blanc, Frederic [2 ]
Giroux, Marianne [1 ]
Vermersch, Patrick [1 ]
De Seze, Jerome [2 ]
机构：
[1] Univ Lille Nord France, Lille, France
[2] Univ Strasbourg, Strasbourg, France
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P02141
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Risk Stratification for Progressive Multifocal Leukoencephalopathy (PML) in MS Patients: Role of Prior Immunosuppressant Use, Natalizumab-Treatment Duration, and Anti-JCV Antibody Status
    Sandrock, Alfred
    Hotermans, Christophe
    Richman, Sandra
    Natarajan, Amy
    Lee, Sophia
    Plavina, Tatiana
    Bloomgren, Gary
    Subramanyam, Meena
    Bozic, Carmen
    NEUROLOGY, 2011, 76 (09) : A248 - A248
  • [42] Anti-JCV IgG sero-conversion during treatment with natalizumab (especially to high JCV index values) co-incides with presence of anti-JCV IgM antibodies
    Schneider-Hohendorf, T.
    Hirsch, H. H.
    Weissbach, F.
    Pignolet, B.
    Bucciarelli, F.
    Brassat, D.
    Wiendl, H.
    Schwab, N.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 856 - 856
  • [43] The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings
    Kolcava, Jan
    Hulova, Monika
    Benesova, Yvonne
    Bednarik, Josef
    Stourac, Pavel
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 30 : 187 - 191
  • [44] Stability of antibody titers to JCV in patients under treatment with natalizumab
    De Lorenzo, I.
    Puertas Munoz, I.
    Lacruz, L.
    Tallon, A.
    Chamorro, B.
    Alba Suarez, E. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 977 - 977
  • [45] Evaluating results of blood serum anti-JCV antibodies of natalizumab treated multiple sclerosis patients
    Kalamatas, T.
    Protopapas, N.
    Lafionati, A.
    Nella, A.
    Graigos, A.
    Karageorgiou, K.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 458 - 458
  • [46] Anti-JCV antibodies in a Spanish multiple sclerosis cohort
    Dominguez-Mozo, M. I.
    Rus, M.
    Garcia-Martinez, M. A.
    Arias-Leal, A. M.
    Izquierdo, G.
    Arroyo, R.
    Alvarez-Lafuente, R.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 675 - 675
  • [47] PML risk stratification during natalizumab therapy using anti-JCV antibody index and L-selectin
    Schwab, N.
    Schneider-Hohendorf, T.
    Pignolet, B.
    Spadaro, M.
    Bertolotto, A.
    Brassat, D.
    Wiendl, H.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 16 - 16
  • [48] JCV-DNA testing during natalizumab treatment is complementary to anti-JCV antibodies for PML risk stratification
    Laroni, A.
    McDermott, J. L.
    Grimaldi, L.
    Gallo, P.
    Sormani, M. P.
    Bertolotto, A.
    Giacomazzi, C. G.
    Gandoglia, I.
    Martini, I.
    Vitello, G.
    Rinaldi, F.
    Barzon, L.
    Militello, V.
    Pizzorno, M.
    Bandini, F.
    Capello, E.
    Palu, G.
    Uccelli, A.
    Mancardi, G. L.
    Varnier, O. E.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S458 - S459
  • [49] Serum Anti-JCV Antibody Status in Western Australian Patients With Multiple Sclerosis
    Fabis-Pedrini, Marzena
    Jeereddy, Shaila
    Carroll, William
    Kermode, Allan
    NEUROLOGY, 2019, 92 (15)
  • [50] A longitudinal study of anti-JCV antibody serostatus among multiple sclerosis patients
    Sellami, Sirine
    Moalla, Khadija
    Bouattour, Nadia
    Sakka, Salma
    Farhat, Nouha
    Daoud, Sawsan
    Damak, Mariem
    Mhiri, Chokri
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
12345